文献速递肥胖与代谢综合征糖尿病

老年人群肥胖的管理策略

Approach to Obesity in the Older Population.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

本文综述老年肥胖(≥65岁)管理策略的转变:从担忧减重致肌少症转向积极干预。生活方式干预(适度能量限制、足量蛋白与微量营养素、有氧加抗阻运动)可安全减重并改善衰弱指标,持续减重可预防或改善糖尿病;减重药物(如利拉鲁肽)及减重手术为后续选择,但需个体化评估风险获益。

要点

  • 生活方式干预是老年肥胖管理基础,可安全减重并改善衰弱指标。
  • 持续减重可预防或改善老年肥胖者的糖尿病。
  • 减重药物和手术为后续选择,需个体化评估风险获益。

核心结论

  • 老年肥胖者减重是安全的,积极管理策略正逐渐替代被动观望。
  • 生活方式干预可改善衰弱指标并预防或改善糖尿病。
  • 减重药物和手术作为后续治疗层级,不应仅因年龄而拒绝。

研究设计与样本

  • 本文为综述,总结老年肥胖(年龄≥65岁)的管理策略与证据。

主要发现

  • 包含适度能量限制、年龄适配蛋白质和微量营养素摄入、以及个体化有氧和抗阻运动的生活方式干预,可诱导减重并改善衰弱指标。
  • 持续减重可预防或改善糖尿病。
  • 利拉鲁肽等GLP-1类似物的安全性和心血管健康获益已在老年肥胖合并2型糖尿病患者中获证实。
  • 减重手术可在老年人中安全实施,作为最后治疗层级。

关键数值与推荐

  • 生活方式干预包括减少但充足的能量摄入、年龄适配的蛋白质和微量营养素摄入、以及针对个人限制定制的有氧和抗阻运动。
  • 减重药物(如利拉鲁肽)作为额外治疗层级,其安全性和心血管获益已在老年肥胖合并2型糖尿病患者中获证实。
  • 减重手术作为最后治疗层级,选择需良好术前功能状态、个体化考虑肥胖后遗症,并依赖高经验中心及短期和长期综合护理支持。

临床怎么用

  • 对老年肥胖者应积极评估并启动生活方式干预,包括适度能量限制、足量蛋白质与微量营养素及个体化运动。
  • 对合并糖尿病前期或其他肥胖相关共病的老年肥胖者,不应仅因年龄而拒绝减重药物。
  • 考虑减重手术时需仔细评估风险获益并告知候选者,选择高经验中心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Until recently, weight loss in older obese people was feared because of ensuing muscle loss and frailty. Facing overall increasing longevity, high rates of obesity in older individuals (age ≥ 65 years) and a growing recognition of the health and functional cost of the number of obesity years, abetted by evidence that intentional weight loss in older obese people is safe, this approach is gradually, but not unanimously, being replaced by more active principles. Lifestyle interventions that include reduced but sufficient energy intake, age-adequate protein and micronutrient intake, coupled with aerobic and resistance exercise tailored to personal limitations, can induce weight loss with improvement in frailty indices. Sustained weight loss at this age can prevent or ameliorate diabetes. More active steps are controversial. The use of weight loss medications, particularly glucagon-like peptide-1 analogs (liraglutide as the first example), provides an additional treatment tier. Its safety and cardiovascular health benefits have been convincingly shown in older obese patients with type 2 diabetes mellitus. In our opinion, this option should not be denied to obese individuals with prediabetes or other obesity-related comorbidities based on age. Finally, many reports now provide evidence that bariatric surgery can be safely performed in older people as the last treatment tier. Risk-benefit issues should be considered with extreme care and disclosed to candidates. The selection process requires good presurgical functional status, individualized consideration of the sequels of obesity, and reliance on centers that are highly experienced in the surgical procedure as well as short-term and long-term subsequent comprehensive care and support.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Buch A, Marcus Y, Shefer G, et al. Approach to Obesity in the Older Population. J Clin Endocrinol Metab. 2021. PMID: 34406394. doi:10.1210/clinem/dgab359

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。